Kidney cysts in patients with HOGA1 variants
Clinical Nephrology · 2023
DOI: 10.5414/cn110939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nephrology, 2023. Verfasst von Dipal M Patel und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cysts, Hyperoxaluria, Primary, Kidney Calculi, Oxo-Acid-Lyases. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
In an era of increased accessibility to genetic testing, nephrologists may be able to better understand pathophysiologic mechanisms by which their patients develop specific conditions. In this study, we describe clinical and genetic findings of two patients with kidney cysts, who were found to have variants in HOGA1, a mitochondrial 4-hydroxy-2-oxoglutarate aldolase enzyme associated with primary hyperoxaluria type 3 and the development of oxalate-containing kidney stones. We describe possible mechanisms by which mutations in this enzyme could result in the kidney cyst formation seen in our two patients. We propose that patients with mutations in HOGA1 are predisposed to crystal or stone deposition, tubule dilation, and inflammasome activation, which can result in kidney cyst formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Patel, D. M., Page, N., & Dahl, N. K. (2023). Kidney cysts in patients with HOGA1 variants. Clinical Nephrology. https://doi.org/10.5414/cn110939
Vancouver
Patel DM, Page N, Dahl NK. Kidney cysts in patients with HOGA1 variants. Clinical Nephrology. 2023. doi:10.5414/cn110939
BibTeX
@article{Patel2023,
author = {Patel, Dipal M and Page, Nicolas and Dahl, Neera K},
title = {Kidney cysts in patients with HOGA1 variants},
journal = {Clinical Nephrology},
year = {2023},
doi = {10.5414/cn110939}
}
EUVIMED